Biliary atresia (BA) is a rare and severe congenital disorder with a significant challenge for prenatal diagnosis. This study, registered at the Chinese Clinical Trial Registry (ChiCTR2200059705), aimed to develop an intelligent model to…
Continue Reading
Health ecosystem players in China are starting to adopt generative AI models by DeepSek, a new competitor to OpenAI.Recently, NASDAQ-listed e-commerce platform Akso Health Group, which is expanding to medical technology, announced the integration…
Continue Reading
News
[embedded content]
China-based TikTok parent ByteDance releases OmniHuman-1, an AI tool that transforms a single photo into a lifelike video with natural singing and speech. The technology is raising concerns about more advanced and easily…
Digital therapeutics (DTx) are software-driven solutions for prevention, treatment, and management of medical conditions. Despite a pro-DTx momentum in China, global DTx trial assessments overlooked the country. We identified 756 DTx trials in China…
Continue Reading
The Chinese University of Hong Kong and its partners have launched the first medical data space in the Guangdong-Hong Kong-Macao Greater Bay Area. This data space, according to a media release, provides opportunities for medical collaboration…
Continue Reading
News
China-based AI startup DeepSeek introduces a low-cost, open-source AI model that rivals leading US technologies, sending US tech stocks sharply down. DeepSeek, which is free to use and can be run locally on modest…
Continue Reading
The U.S. stock market, especially the tech-heavy NASDAQ, was deeply (no pun intended) rattled by a Chinese AI upstart called DeepSeek on Monday. It appears to have accomplished much of what large language models…
Continue Reading
Cornerstone Robotics (CSR), a surgical robotics company, announced it raised more than $70 million in Series C funding. EQT led the round with participation from Qiming Venture Partners, Alpha JWC Ventures, the Innovation and Technology…
Continue Reading
Cardiovascular diseases (CVDs) pose a significant health burden in China, where the large population and vast geography limit access to care. Telehealth (tHealth) services provide a virtual model of care that can enhance CVD…
Continue Reading
Hospitals from China will be partaking in existing research in Singapore that aims to develop precise and personalised solutions to early detect and manage symptoms of cardiovascular diseases specific to the Asian population. Early this…
Continue Reading
